Menu Search
Equities

Trenchant Technologies Capital Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5730:FRA

Trenchant Technologies Capital Corp

Actions
  • Price (EUR)0.02
  • Today's Change0.00 / 0.00%
  • Shares traded700.00
  • 1 Year change-81.82%
  • Beta0.2660
Data delayed at least 15 minutes, as of Feb 16 2026 07:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Trenchant Technologies Capital Corp. is an investment issuer company. The Company is focused primarily on seeking investment in companies introducing novel technologies, including Artificial Intelligence and Quantum Computing, to traditional businesses primarily in the medical, biomedical, and technologies sectors. It has entered into an agreement to acquire Limitless Quantum Computing Solutions Inc. Limitless Quantum is engaged in developing a quantum-resistant blockchain security platform. The Company has also acquired a 20% ownership interest in GNQ Insilico from the parent company, My Next Health Inc. GNQ Insilico is a health tech company. GNQ Insilico's technology platform can accelerate research processes, enhance genomic insights, and contribute to advancements in precision medicine and healthcare.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-4.78m
  • Incorporated2009
  • Employees--
  • Location
    Trenchant Technologies Capital CorpSuite 2380 1055 West, Hastings StVANCOUVER V6E 2E9CanadaCAN
  • Phone+1 (604) 307-4274
  • Fax+1 (604) 307-4274
  • Websitehttps://www.trenchanttechcap.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.